E13 — Other specified diabetes mellitus
Part of Chapter 4: Endocrine, nutritional and metabolic diseases , block Diabetes mellitus (E08-E13) .
Official Notes
Includes
diabetes mellitus due to genetic defects of beta-cell function
Includes
diabetes mellitus due to genetic defects in insulin action
Includes
postpancreatectomy diabetes mellitus
Includes
postprocedural diabetes mellitus
Includes
secondary diabetes mellitus NEC
Use Additional Code
code to identify control using:
Use Additional Code
injectable non-insulin antidiabetic drugs ( Z79.85 )
Use Additional Code
insulin ( Z79.4 )
Use Additional Code
oral antidiabetic drugs ( Z79.84 )
Use Additional Code
oral hypoglycemic drugs ( Z79.84 )
Excludes1
diabetes (mellitus) due to autoimmune process ( E10 .-)
Excludes1
diabetes (mellitus) due to immune mediated pancreatic islet beta-cell destruction ( E10 .-)
Excludes1
diabetes mellitus due to underlying condition ( E08 .-)
Excludes1
drug or chemical induced diabetes mellitus ( E09 .-)
Excludes1
gestational diabetes ( O24.4- )
Excludes1
neonatal diabetes mellitus ( P70.2 )
Excludes1
type 1 diabetes mellitus ( E10 .-)
Child Codes
- E13.0 Other specified diabetes mellitus with hyperosmolarity Has subcodes
- E13.1 Other specified diabetes mellitus with ketoacidosis Has subcodes
- E13.2 Other specified diabetes mellitus with kidney complications Has subcodes
- E13.3 Other specified diabetes mellitus with ophthalmic complications Has subcodes
- E13.4 Other specified diabetes mellitus with neurological complications Has subcodes
- E13.5 Other specified diabetes mellitus with circulatory complications Has subcodes
- E13.6 Other specified diabetes mellitus with other specified complications Has subcodes
- E13.8 Other specified diabetes mellitus with unspecified complications Billable
- E13.9 Other specified diabetes mellitus without complications Billable
Referenced By
Official notes on these codes cite E13.
FY 2027 effective October 1, 2026 · CDC NCHS and CMS